Abstract
Objective:
This study investigated changes in the quality of life of men and women who participated in a primary care-based weight loss intervention program.
Methods:
Participants were enrolled in a 2-year randomized clinical trial (POWER-UP) conducted at the University of Pennsylvania and in six affiliated primary care practices. Inclusion criteria included the presence of obesity (body mass index of 30–50 kg m−2) and at least two components of the metabolic syndrome.
Main Outcome Measures:
Quality of life was assessed by three measures: the Short Form Health Survey (SF-12); the Impact of Weight on Quality of Life-Lite; and the EuroQol-5D.
Results:
Six months after the onset of treatment, and with a mean weight loss of 3.9±0.3 kg, participants reported significant improvements on all measures of interest with the exception of the Mental Component Score of the SF-12. These changes remained significantly improved from baseline to month 24, with the exception of the EuroQol-5D. Many of these improvements were correlated with the magnitude of weight loss and, for the most part, were consistent across gender and ethnic group.
Conclusions:
Individuals with obesity and components of the metabolic syndrome reported significant improvements in most domains of the quality of life with a modest weight loss of 3.7% of initial weight, which was achieved within the first 6 months of treatment. The majority of these improvements were maintained at month 24, when participants had lost 3.0% of their weight.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sarwer DB, Lavery M, Spitzer JC . A review of the relationships between extreme obesity quality of life, and sexual function. Obes Surg 2012; 22: 668–676.
Fabricatore AN, Wadden TA, Sarwer DB, Faith MS . Health-related quality of life and symptoms of depression in extremely obese persons seeking bariatric surgery. Obes Surg 2005; 15: 304–309.
Kolotkin RL, Crosby RD, Pendleton R, Strong M, Gress RE, Adams T . Health-related quality of life in patients seeking gastric bypass surgery vs non-treatment-seeking controls. Obes Surg 2003; 13: 371–377.
Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Engel SG, Adams TD . Health and health-related quality of life: differences between men and women who seek gastric bypass surgery. Surg Obes Relat Dis 2008; 4: 651–658.
Fabricatore AN, Wadden TA, Sarwer DB, Faith MS . Depressive symptoms as a function of body mass index and health-related quality of life in the treatment seeking obese adults. Obes Res 2003; 11: A10.
Schok M, Greenen R, van Antwerpen T, de Wit P, Brand N, van Ramshorst B . Quality of life after laparoscopic adjustable gastric banding for severe obesity: postoperative and retrospective preoperative evaluations. Obes Surg 2000; 10: 502–508.
Fontaine KR, Cheskin LJ, Barofsky I . Health-related quality of life in obese persons seeking treatment. J Fam Pract 1996; 43: 265–270.
Heo M, Allison DB, Faith MS, Zhu S, Fontaine KR . Obesity and quality of life: mediating effects of pain and comorbidities. Obes Res 2003; 11: 209–216.
Jia H, Lubetkin EI . The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health 2005; 27: 156–164.
Tsai AG, Wadden TA, Sarwer DB, Berkowitz RI, Womble LG, Hesson LA et al. Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction. Obesity 2008; 16: 59–63.
Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO . Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 2007; 15: 511–521.
Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD . Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis 2009; 5: 250–256.
Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K . Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med 2009; 169: 163–171.
Rejeski WJ, Focht BC, Messier SP, Morgan T, Pahor M, Penninx B . Obese, older adults with knee osteoarthritis: weight loss, exercise, and quality of life. Health Psychol 2002; 21: 419–426.
Kaukua J, Pekkarinen T, Sane T, Mustajoki P . Health-related quality of life in WHO class II-III obese men losing weight with very-low-energy diet and behaviour modification: a randomised clinical trial. Int J Obes Relat Metab Disord 2002; 26: 487–495.
Kaukua JK, Pekkarinen TA, Rissanen AM . Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes. Int J Obes Relat Metab Disord 2004; 28: 600–605.
Karlsson J, Sjostrom L, Sullivan M . Swedish Obese Subjects (SOS): an intervention study of obesity: two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998; 22: 113–126.
Maciejewski ML, Patrick DL, Williamson DF . A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life. J Clin Epidemiol 2005; 58: 568–578.
Sarwer DB, Wadden TA, Moore RH, Eisenberg MH, Raper SE, Williams NN . Changes in quality of life and body image after gastric bypass surgery. Surg Obes Relat Dis 2010; 6: 608–614.
Derbas J, Vetter M, Volger S, Khan Z, Panigrahi E, Tsai AG et al. Improving weight management in primary care practice: a possible role for auxiliary health professionals collaborating with primary care physicians. Obes Weight Manag 2009; 5: 210–215.
Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365: 1969–1979.
Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Ware J Jr, Kosinski M, Keller SD . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.
Kolotkin Rl, Crosby RD, Kosloski KD, Rhys Williams G . Development of a brief measure to assess quality of life in obesity. Obes Res 2001; 9: 102–111.
Kolotkin RL, Norquist JM, Crosby RD, Suryawanshi S, Teixeira PJ, Heymsfield SB et al. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes 2009; 7: 53.
Cheung K, Oemar M, Oppe M, Rabin R . EQ-5D User Guide: Basic Information on how to Use the EQ-5D. Version 2.0. EuroQoL Group: Rotterdam, 2009.
Acknowledgements
This research was supported by grants from the National Heart, Lung and Blood Institute (U01-HL087072) and the National Institute of Diabetes and Digestive and Kidney Diseases (K24-DK065018).
This article is published as part of a supplement, sponsored by the Center for Weight and Eating Disorders—University of Pennsylvania.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
DBS discloses that he has relationships with the following companies: Allergan, BariMD, BaroNova, Enteromedics and Galderma. DAS has also received grant support from the National Institutes of Health (NIH). TAW serves on the advisory boards of Novo Nordisk and Orexigen Therapeutics, which are developing weight loss medications, as well as of Alere and the Cardiometabolic Support Network, which provide behavioral weight loss programs. TAW has also served as a consultant for Boehringer Ingelheim, and has received grant support from the National Institutes of Health (NIH/NIDDK and NIH/NHLBI). The remaining authors declare no conflict of interest.
Appendix
Appendix
POWER-UP Research Group: Investigators and Research Coordinators
Academic investigators at the Perelman School of Medicine at the University of Pennsylvania were Thomas A Wadden, PhD (principal investigator), David B Sarwer, PhD (co-principal investigator), Robert I Berkowitz, MD, Jesse Chittams, MS, Lisa Diewald, MS, RD, Shiriki Kumanyika, PhD, Renee Moore, PhD, Kathryn Schmitz, PhD, Adam G Tsai, MD, MSCE, Marion Vetter, MD and Sheri Volger, MS, RD.
Research coordinators at the University of Pennsylvania were Caroline H Moran, BA, Jeffrey Derbas, BS, Megan Dougherty, BS, Zahra Khan, BA, Jeffrey Lavenberg, MA, Eva Panigrahi, MA, Joanna Evans, BA, Ilana Schriftman, BA, Dana Tioxon, Victoria Webb, BA and Catherine Williams-Smith, BS.
POWER-UP Research Group: Participating Sites and Clinical Investigators
PennCare–Bala Cynwyd Medical Associates: Ronald Barg, MD, Nelima Kute, MD, David Lush, MD, Celeste Mruk, MD, Charles Orellana, MD and Gail Rudnitsky, MD (primary care providers); Angela Monroe (lifestyle coach); Lisa Anderson (practice administrator).
PennCare–Internal Medicine Associates of Delaware County: David E Eberly, MD, Albert H Fink Jr, MD, Kathleen Malone, CRNP, Peter B Nonack, MD, Daniel Soffer, MD, John N Thurman, MD and Marc J Wertheimer, MD (primary care providers); Barbara Jean Shovlin, Lanisha Johnson (lifestyle coaches); Jill Esrey (practice administrator).
PennCare–Internal Medicine Mayfair: Jeffrey Heit, MD, Barbara C Joebstl, MD and Oana Vlad, MD (primary care providers); Rose Schneider, Tammi Brandley (lifestyle coaches); Linda Jelinski (practice administrator).
Penn Presbyterian Medical Associates: Joel Griska, MD, Karen J Nichols, MD, Edward G Reis, MD, James W Shepard, MD and Doris Davis-Whitely, PA (primary care providers); Dana Tioxon (lifestyle coach); Charin Sturgis (practice administrator).
PennCare–University City Family Medicine: Katherine Fleming, CRNP, Dana B Greenblatt, MD, Lisa Schaffer, DO, Tamara Welch, MD and Melissa Rosato, MD (primary care providers); Eugonda Butts, Marta Ortiz, Marysa Nieves and Alethea White (lifestyle coach); Cassandra Bullard (practice administrator).
PennCare–West Chester Family Practice: Jennifer DiMedio, CRNP, Melanie Ice, DO, Brandt Loev, DO, John S Potts, DO and Christine Tressel, DO (primary care providers); Iris Perez, Penny Rancy and Dianne Rittenhouse (lifestyle coaches); Joanne Colligan (practice administrator).
Rights and permissions
About this article
Cite this article
Sarwer, D., Moore, R., Diewald, L. et al. The impact of a primary care-based weight loss intervention on the quality of life. Int J Obes 37 (Suppl 1), S25–S30 (2013). https://doi.org/10.1038/ijo.2013.93
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2013.93
Keywords
This article is cited by
-
Remotely delivered and clinic-delivered lifestyle interventions produced similar effects on the diet quality of participants
Journal of Public Health (2024)
-
Feasibility and outcomes of using DIALOG+ in primary care to improve quality of life and mental distress of patients with long-term physical conditions: an exploratory non-controlled study in Bosnia and Herzegovina, Colombia and Uganda
BMC Primary Care (2023)
-
Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study
BMC Women's Health (2022)
-
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Diabetes Therapy (2021)
-
Health-related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: a case-control study
Health and Quality of Life Outcomes (2020)